Affiliated Hospital of Bengbu Medical College

Bengbu 233004

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Hepatocellular, Esophageal Squamous Cell Carcinoma

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation — Completed